2021 - Page 11 of 17 - Customs & International Trade Law Firm

FDA Further Extends UFI Flexibility For Food Facility Registrations

Background on Food Facility Registration

The Federal Food, Drug, and Cosmetic Act (“FD&C”) requires domestic and foreign facilities that manufacture, process, pack, or hold food for human or animal consumption in the United States to register with the U.S. Food and Drug Administration (“FDA”). Additionally, the FDA Food Safety Modernization Act (“FSMA”) amended the food facility registration requirements in the FD&C to require domestic and foreign facilities to submit certain additional new information to the FDA and renew their registrations every other year during the period beginning on October 1 and ending on December 31 of each even-numbered year.

[…]

By Jennifer Diaz|2022-07-08T09:34:18-04:00April 22, 2021|Best Practices, FDA Issues, Food, FSMA, Import, International Trade, Pre-compliance, U.S. Food and Drug Administration (FDA)|0 Comments

Understanding Strategic Trade Authorization

Co-Authored by Sharath Patil

Background on Export Administration Regulations

Over 95% of the world’s consumers are outside of the United States. Opportunities abound for U.S. companies that export. However, exporting is a privilege and not a right. U.S. exporters have an important responsibility to adhere to U.S. export control laws, including the Export Administration Regulations (“EAR”).

Administered by the U.S. Commerce Department, the EAR is a set of regulations which governs whether U.S. persons may export or transfer goods, software, and technology outside of the United States or to non-U.S. citizens. U.S. exporters have an important responsibility to adhere to the EAR. Violations of the EAR carry hefty civil and criminal penalties. Exporters can pay hundreds of thousands of dollars in penalties, lose export privileges, and even be imprisoned.

[…]

By Jennifer Diaz|2022-07-08T09:32:26-04:00April 20, 2021|EAR, Enforcement, Export, International Trade, U.S. Bureau of Industry and Security (BIS), U.S. Department of Commerce (DOC)|0 Comments

Anti-Circumvention, EAPA, Dumping Duties & the Spreadability of Cases

This one-hour webinar will provide an overview of AD/CVD, U.S. Customs and Border Protection’s enforcement actions and investigative process, as well as a review of EAPA regulations and provide insights on best practices to protect your company in this contentious area of U.S. Customs and Border Protection enforcement.

Background on EAPA

The Enforce and Protect Act of 2015 (EAPA) allows U.S. Customs and Border Protection (“CBP”) to investigate whether a company has evaded anti-dumping and countervailing (AD/CVD) duties in an on-the-record investigation. EAPA enforcement has increased considerably in recent years. In fact, in Fiscal Year 2020, CBP collected $287 million in duties via EAPA enforcement – this is a 500 percent increase since the beginning of the EAPA program in FY 2017.

On April 21, 2021 at 12:00 PM, Jennifer Diaz and David Craven will present a webinar on Anti-Circumvention/EAPA/Dumping Duties & the Spreadability of Cases.

[…]

By Jennifer Diaz|2021-07-29T12:22:24-04:00April 19, 2021|AD/CVD, China, Enforcement, Import, International Trade, Pre-compliance, U.S. Customs and Border Protection (CBP), U.S. Department of Commerce (DOC)|2 Comments

The CAPTA List – An Introduction

Co-Authored by Sharath Patil

What’s the CAPTA List?

The Correspondent Account or Payable-Through Account Sanctions List (“CAPTA” List”) is a list maintained by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”). The CAPTA List identifies foreign financial institutions that are prohibited or in some way restricted from maintaining a correspondent account or a payable-through account in the United States.

[…]

By Jennifer Diaz|2021-07-29T12:23:23-04:00April 15, 2021|Export, International Trade, Iran, U.S. Office of Foreign Assets Control (OFAC)|0 Comments

301 Exclusion Extensions for COVID-19 Related Products

On March 10, 2021, via Federal Register Notice ( 86 FR 13785), the United States Trade Representative (USTR) announced that 99 medical product exclusions will be extended from March 31, 2021, to September 30, 2021. This action extends a previous USTR action which extended these exclusions from December 31, 2020, to March 31, 2020 (85 FR 85831). […]

By Jennifer Diaz|2022-07-08T09:23:54-04:00April 13, 2021|China, China Trade War, COVID-19, Customs Expert, Expert, HTSUS, Import, Intellectual Property Rights, International Business, International Law, International Trade, Investigation, Supply Chain, Trade Policy, U.S. Customs and Border Protection (CBP), U.S. Office of the United States Trade Representative (USTR)|2 Comments

Previous 101112 Next